Curis (CRIS) EBITDA (2010 - 2026)

Curis (CRIS) has reported EBITDA for 17 consecutive years, with -$9.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 20.47% year-over-year to -$9.9 million; the trailing twelve-month figure through Jun 2026 stood at -$8.8 million (up 76.92% YoY), and the FY2025 full-year result was -$5.7 million, up 87.17% from the prior year.
• EBITDA improved to -$9.9 million in Q2 2026 per CRIS's latest filing, from -$11.5 million in the prior quarter.
• Across five years, EBITDA topped out at $19.6 million in Q4 2025 and bottomed at -$15.1 million in Q1 2022.
• Historically, EBITDA has averaged -$9.6 million across 5 years, with a median of -$11.6 million in 2023.
• The sharpest annual moves came in 2022 and 2025: EBITDA plunged 71.97% in 2022, then surged 318.13% in 2025.
• Over 5 years, EBITDA stood at -$10.2 million in 2022, then dropped by 19.36% to -$12.2 million in 2023, then climbed by 26.27% to -$9.0 million in 2024, then soared by 318.13% to $19.6 million in 2025, then slumped by 150.67% to -$9.9 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$9.9 million, -$11.5 million, and $19.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.